‘Prioritising profit’: Australians regularly prescribed medicinal cannabis with very high THC levels
Researchers from Monash University have raised concerns that Australian doctors are prescribing medicinal cannabis with THC levels significantly higher than those tested in clinical trials. The study highlights a lack of regulatory oversight, as only a small fraction of available products have undergone formal evaluation.
Why it matters
This highlights a potential public health risk where patients are using high-potency substances without sufficient evidence of safety or efficacy.
Researchers evaluated the efficacy and safety of higher THC potency medicinal cannabis products, finding that higher-dose products are commonly being prescribed in Australia. Photograph: Matt Hunt/NurPhoto/Shutterstock Researchers evaluated the efficacy and safety of higher THC potency medicinal cannabis products, finding that higher-dose products are commonly being prescribed in Australia. Photograph: Matt Hunt/NurPhoto/Shutterstock Health ‘Prioritising profit’: Australians regularly prescribed medicinal cannabis with very high THC levels Exclusive: Of more than 1,000 medicinal cannabis products available, only two have been evaluated by the drug regulator
Follow our Australia news live blog for latest updates
Get our breaking news email , free app or daily news podcast
Prefer the Guardian on Google Doctors are commonly prescribing high-dose medicinal cannabis containing up to four times the concentration of THC tested in clinical trials, a review has found.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in